SMTL ID : 2f7i.1

Human transthyretin (TTR) complexed with diflunisal analogues- TTR. 2',6'-Difluorobiphenyl-4-carboxylic Acid

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

homo-tetramer

Ligands

4 x 26C: 2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID(Non-covalent)

26C.1: 13 residues within 4Å: Chain A: K.15, L.17, A.108, A.109, L.110, S.117 Chain C: K.15, L.17, A.108, A.109, L.110, S.117 Ligands: 26C.3 9 PLIP interactions: 5 interactions with chain C, 4 interactions with chain A Hydrophobic interactions: C:L.17, C:A.108, C:L.110, C:L.110, A:L.17, A:A.108, A:L.110 Salt bridges: C:K.15, A:K.15 26C.2: 13 residues within 4Å: Chain B: K.15, L.17, A.108, L.110, S.117, T.119 Chain D: K.15, L.17, A.108, L.110, S.117, T.119 Ligands: 26C.4 9 PLIP interactions: 4 interactions with chain D, 5 interactions with chain B Hydrophobic interactions: D:L.17, D:A.108, D:L.110, B:L.17, B:A.108, B:L.110, B:T.119 Salt bridges: D:K.15, B:K.15 26C.3: 13 residues within 4Å: Chain A: K.15, L.17, A.108, A.109, L.110, S.117 Chain C: K.15, L.17, A.108, A.109, L.110, S.117 Ligands: 26C.1 9 PLIP interactions: 4 interactions with chain C, 5 interactions with chain A Hydrophobic interactions: C:L.17, C:A.108, C:L.110, A:L.17, A:A.108, A:L.110, A:L.110 Salt bridges: C:K.15, A:K.15 26C.4: 13 residues within 4Å: Chain B: K.15, L.17, A.108, L.110, S.117, T.119 Chain D: K.15, L.17, A.108, L.110, S.117, T.119 Ligands: 26C.2 9 PLIP interactions: 5 interactions with chain D, 4 interactions with chain B Hydrophobic interactions: D:L.17, D:A.108, D:L.110, D:T.119, B:L.17, B:A.108, B:L.110 Salt bridges: D:K.15, B:K.15

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Adamski-Werner, S.L. et al., Diflunisal Analogues Stabilize the Native State of Transthyretin. Potent Inhibition of Amyloidogenesis. J.Med.Chem. (2004)

Release Date

2005-12-13

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence